Dipak Panigrahy Selected Research

Fatty Acids (Saturated Fatty Acids)

2/2024	Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase.
1/2021	Carcinogenesis: Failure of resolution of inflammation?
4/2013	Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.
2/2012	Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dipak Panigrahy Research Topics

Disease

42	Neoplasms (Cancer) 03/2024 - 10/2002
28	Inflammation (Inflammations) 02/2024 - 07/2005
8	Carcinogenesis 02/2024 - 05/2004
8	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2002
5	Cytokine Release Syndrome 10/2021 - 01/2020
4	Pathologic Neovascularization 01/2023 - 09/2010
4	Infections 01/2022 - 01/2020
3	COVID-19 01/2022 - 01/2020
3	Corneal Neovascularization 08/2013 - 01/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2019
2	Thrombosis (Thrombus) 01/2022 - 01/2020
2	Hypersensitivity (Allergy) 01/2020 - 09/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2018
2	Retinal Neovascularization 03/2014 - 09/2010
2	Glioblastoma (Glioblastoma Multiforme) 10/2013 - 09/2010
1	Cardiomyopathies (Cardiomyopathy) 02/2024
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2023
1	Adenocarcinoma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Fibrosis (Cirrhosis) 10/2020
1	Ischemia 10/2020
1	Reperfusion Injury 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 10/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Pain (Aches) 01/2020
1	Pathologic Processes 01/2020
1	Fever (Fevers) 01/2020
1	Coronavirus Infections 01/2020
1	Human Influenza (Influenza) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019

Drug/Important Bio-Agent (IBA)

17	LipidsIBA 01/2023 - 12/2010
13	EicosanoidsIBA 01/2023 - 12/2010
12	Epoxide HydrolasesIBA 02/2024 - 01/2012
9	CytokinesIBA 01/2022 - 10/2012
8	AutacoidsIBA 01/2022 - 12/2010
6	Arachidonic Acid (Vitamin F)IBA 01/2021 - 12/2010
6	AcidsIBA 01/2020 - 04/2013
6	LigandsIBA 01/2019 - 10/2002
5	EnzymesIBA 02/2024 - 11/2011
5	ProstaglandinsIBA 01/2023 - 12/2010
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2014 - 12/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 10/2002
4	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 02/2012
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2024 - 02/2012
4	LipoxinsIBA 01/2023 - 01/2019
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023 - 07/2014
3	LeukotrienesIBA 01/2021 - 12/2010
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020 - 11/2011
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2014 - 03/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2010 - 02/2007
2	Celecoxib (Celebrex)FDA Link 01/2023 - 09/2010
2	Dinoprostone (PGE2)FDA Link 01/2023 - 10/2021
2	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 01/2022 - 09/2010
2	CarcinogensIBA 01/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
2	Lipoxygenase (Lipoxygenase-1)IBA 10/2014 - 03/2014
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2014 - 09/2010
2	Retinaldehyde (Retinal)IBA 03/2014 - 08/2013
2	Oxygen (Dioxygen)IBA 03/2014 - 10/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2012 - 05/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 05/2004
2	CytochromesIBA 12/2011 - 12/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2010 - 05/2008
2	Angiogenesis InhibitorsIBA 09/2010 - 02/2007
2	Rosiglitazone (Avandia)FDA Link 09/2010 - 10/2002
2	EndostatinsIBA 09/2010 - 01/2008
2	PPAR alphaIBA 01/2008 - 02/2007
2	PPAR gammaIBA 07/2005 - 10/2002
1	Immune Checkpoint InhibitorsIBA 02/2024
1	methionine aminopeptidase 2IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	AflatoxinsIBA 01/2021
1	NitrosaminesIBA 01/2021
1	AsbestosIBA 01/2021
1	Enalapril FDA LinkGeneric 10/2020
1	Antihypertensive Agents (Antihypertensives)IBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	Environmental CarcinogensIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Aflatoxin B1 (Aflatoxin B)IBA 01/2020
1	ThromboxanesIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	KetorolacIBA 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	PlatinumIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	ChemokinesIBA 01/2019
1	taxaneIBA 01/2019

Therapy/Procedure

21	Therapeutics 03/2024 - 12/2003
9	Drug Therapy (Chemotherapy) 11/2021 - 09/2010
1	Immunotherapy 02/2024
1	Aftercare (After-Treatment) 01/2022